FURMONERTINIB

Clinical trials for FURMONERTINIB explained in plain language.

Never miss a new study

Get alerted when new FURMONERTINIB trials appear

Sign up with your email to follow new studies for FURMONERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Can a pulsatile drug schedule beat brain metastases in lung cancer?

Disease control Recruiting now

This trial is testing a higher, every-other-day dose of the drug furmonertinib in people with a specific type of lung cancer (EGFR-mutant NSCLC) that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis). The study will compare this high-dose schedule …

Matched conditions: FURMONERTINIB

Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

FURMONERTINIB

Get alerted when new FURMONERTINIB trials appear

Can a pulsatile drug schedule beat brain metastases in lung cancer?